MedPath
HSA Approval

CARBIMAZOLE 5 TABLET 5 mg

SIN06923P

CARBIMAZOLE 5 TABLET 5 mg

CARBIMAZOLE 5 TABLET 5 mg

March 23, 1992

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

H03BB01

carbimazole

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

CARBIMAZOLE

5 mg

Carbimazole

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CARBIMAZOLE 5 TABLET 5 mg - HSA Approval | MedPath